BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30206235)

  • 1. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.
    Wang H; Guo W; Mitra J; Hegde PM; Vandoorne T; Eckelmann BJ; Mitra S; Tomkinson AE; Van Den Bosch L; Hegde ML
    Nat Commun; 2018 Sep; 9(1):3683. PubMed ID: 30206235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Mechanisms of DNA Repair Defects in Fused in Sarcoma-Associated Neurodegeneration: Stage Set for DNA Repair-Based Therapeutics?
    Wang H; Hegde ML
    J Exp Neurosci; 2019; 13():1179069519856358. PubMed ID: 31217692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RT
    Wang H; Rangaswamy S; Kodavati M; Mitra J; Guo W; Guerrero EN; Van Den Bosch L; Hegde ML
    Mol Brain; 2019 Dec; 12(1):103. PubMed ID: 31801573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
    Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
    Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage.
    Rulten SL; Rotheray A; Green RL; Grundy GJ; Moore DA; Gómez-Herreros F; Hafezparast M; Caldecott KW
    Nucleic Acids Res; 2014 Jan; 42(1):307-14. PubMed ID: 24049082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner.
    Fortuna TR; Kour S; Anderson EN; Ward C; Rajasundaram D; Donnelly CJ; Hermann A; Wyne H; Shewmaker F; Pandey UB
    Acta Neuropathol; 2021 Sep; 142(3):515-536. PubMed ID: 34061233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects.
    Mitra J; Guerrero EN; Hegde PM; Liachko NF; Wang H; Vasquez V; Gao J; Pandey A; Taylor JP; Kraemer BC; Wu P; Boldogh I; Garruto RM; Mitra S; Rao KS; Hegde ML
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4696-4705. PubMed ID: 30770445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
    Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
    Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy.
    Marrone L; Poser I; Casci I; Japtok J; Reinhardt P; Janosch A; Andree C; Lee HO; Moebius C; Koerner E; Reinhardt L; Cicardi ME; Hackmann K; Klink B; Poletti A; Alberti S; Bickle M; Hermann A; Pandey UB; Hyman AA; Sterneckert JL
    Stem Cell Reports; 2018 Feb; 10(2):375-389. PubMed ID: 29358088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons.
    Wang WY; Pan L; Su SC; Quinn EJ; Sasaki M; Jimenez JC; Mackenzie IR; Huang EJ; Tsai LH
    Nat Neurosci; 2013 Oct; 16(10):1383-91. PubMed ID: 24036913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
    Shang Y; Huang EJ
    Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
    Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
    Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations.
    Di Salvio M; Piccinni V; Gerbino V; Mantoni F; Camerini S; Lenzi J; Rosa A; Chellini L; Loreni F; Carrì MT; Bozzoni I; Cozzolino M; Cestra G
    Cell Death Dis; 2015 Oct; 6(10):e1943. PubMed ID: 26492376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN.
    Nogami M; Ishikawa M; Doi A; Sano O; Sone T; Akiyama T; Aoki M; Nakanishi A; Ogi K; Yano M; Okano H
    Neurobiol Dis; 2021 Jul; 155():105364. PubMed ID: 33857636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted autophagy and neuronal dysfunction in C. elegans knockin models of FUS amyotrophic lateral sclerosis.
    Baskoylu SN; Chapkis N; Unsal B; Lins J; Schuch K; Simon J; Hart AC
    Cell Rep; 2022 Jan; 38(4):110195. PubMed ID: 35081350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.